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Abstract  
 
Aim 
 
To investigate self-management of dietary intake by colorectal cancer patients receiving 
chemotherapy.  
Methods 
A questionnaire was administered to 92 patients with non-metastatic colorectal cancer receiving 
chemotherapy treatment at a UK cancer centre in 2018-19. A maximum variation sample of twenty 
patients who completed the questionnaire were interviewed.  
Results  
More than three in five patients were at nutritional risk but fewer than one in five were concerned 
about dietary intake or weight. Self-management of diet and weight was inconsistent with achieving 
the nutritional intake recommended by clinical guidelines on nutrition in cancer. 
Conclusion 
There is potential for psychoeducation to support change in self-management of nutritional risk, 
with implications for better treatment tolerance and outcomes including quality of life.  
 
Key words 
Colorectal cancer, chemotherapy, nutrition, diet, weight, psychosocial, self-management, 
qualitative, mixed-methods, research  
 
Summary points 
• Malnutrition during cancer treatment is associated with poor treatment tolerance, survival 
and quality of life • Self-management of dietary intake may be an important way to improve treatment 
tolerance and outcomes • Little attention has been given to the facilitation of optimal dietary intake during cancer 
chemotherapy • We found patients with colorectal cancer receiving chemotherapy to be at nutritional risk, 
but unconcerned about their dietary intake • A minority self-managed by taking the healthy diet recommended to reduce risk of disease, 
whilst a majority sought to return to their pre-cancer dietary intake. • Self-management of dietary intake was inconsistent with achieving the recommended 
nutritional intake for patients receiving chemotherapy • There is potential for supportive nutritional care to potentiate chemotherapy in patients 
with colorectal cancer 
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Introduction  
 
This research is about self-management of diet and weight by patients with non-metastatic 
colorectal cancer during chemotherapy treatment.  
 
Background  
 
Eating problems during cancer treatment are common and contribute to malnutrition. Weight loss, an 
indicator of malnutrition, has been observed in 40-92% of patients 65 years and older during 
chemotherapy [1]. Expert consensus is that all patients should have optimal nutritional care 
throughout the course of their cancer [2]. The aim is to prevent malnutrition, thus improving 
treatment tolerance, survival and quality of life [3]. Support for self-management of dietary intake and 
weight is a possible way to help patients maintain their nutritional status and therefore potentiate 
cancer treatment. 
 
Research about eating and gastrointestinal cancer treatments 
 
In 2011, Baldwin et al. [4] conducted a systematic review of oral nutritional interventions in 
malnourished cancer patients. The analysis of 13 studies with 1,414 patients, found improved 
nutritional intake and quality of life. The meta-analysis was of mixed cancer sites and stages, therefore 
did not reveal if sub-groups of patients are more likely to benefit from oral nutritional support. In the 
same year, 2011, Elia critically reviewed studies of oral nutritional support during treatment in 
patients with gastrointestinal cancer [5]. He concluded that the effect on survival and other outcomes 
is unknown because studies were of mixed cancer stages, compliance with oral supplements poor and 
groups of well nourished (who perhaps cannot benefit greatly from nutritional support) mixed with 
malnourished patients with sample sizes insufficient to conduct robust subgroup analysis. He draws 
attention to the proven difficulty in improving dietary intake in real-life situations, for example, when 
a patient becomes too unwell during treatment to adhere to recommended interventions However, 
it is known that weight loss before or during cancer treatment can negatively influence treatment 
outcomes, even in people who are overweight [2]. 
 
Our own systematic search of the literature published since 2011, demonstrated that some sub-
groups of cancer patients are more likely than others to benefit from nutritional support during cancer 
treatment. Patients with head and neck and gastrointestinal cancers are particularly likely to benefit 
[6].  
 
In patients with gastrointestinal cancer, pre-operative oral nutritional supplements can reduce post-
operative surgical site infection rate, post-operative weight loss [7] and serious complications [8]. 
Compliance with oral nutritional supplements in these patients is variable and independent of weight 
loss, appetite and comorbidity, but is dependent on information and education [9]. In patients with 
colorectal cancer followed up after radiotherapy for a median 6.5 years, those who received 
individualised nutritional counselling to maintain protein and energy intake experienced less 
treatment toxicity, better quality of life and lower mortality rate compared with patients randomised 
to either oral supplements and usual diet or usual diet [6, 10]. It is not known if nutritional care can 
achieve similar results for patients receiving chemotherapy for colorectal cancer. 
 
Aim  
 
To investigate self-management of eating problems in patients with colorectal cancer receiving 
chemotherapy to explore the potential for reducing the risk of malnutrition, which contributes to poor 
clinical and patient reported outcomes from treatment.  
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Question 
What practical, social and emotional factors affect eating during chemotherapy treatment and how 
are they self-managed by patients? 
Methods 
 
The research was a mixed-methods qualitative study of sequential design to identify factors affecting 
diet and weight during treatment and how they were self-managed. It was conducted at a cancer 
centre in the UK serving a population of approximately 1.5 million people in 2018/19. The objectives 
were to refine an existing survey questionnaire to investigate the experience of eating and weight 
for patients receiving chemotherapy treatment for colorectal cancer. To administer the survey to all 
eligible patients attending clinics over a 30-week period (approximately 100 patients) and to conduct 
semi-structured exploratory telephone interviews with a sub-set of survey participants (max. 30 
patients). (See Figure 1. Study design). 
 
Eligibility criteria were: 
 • Adults (18 years or older)  • Colorectal cancer diagnosis, non-metastatic (stage I-III) • Capacity to consent • Receiving chemotherapy 
 
 Development of the survey questionnaire 
 
We developed a bespoke questionnaire, selecting items from existing questionnaires, designed and 
evaluated for the identification of eating and weight problems in people with advanced cancer or 
mixed cancer sites. We utilizing the knowledge from our previous systematic review of what is 
known about eating during cancer treatment [5] and development of a cachexia quality of life 
measure: the EORTC CAX24 [10]. We then added the Scored Patient Generated Subjective Global 
Assessment (PG-SGA), which includes the four patient-generated historical components (weight 
history, food intake, symptoms and activities and function – also known as the PG-SGA short form) 
for assessing nutritional risk [12, 13]. A score of 0-1 requires no intervention, 2 to 3 requires 
nutritional education by a dietitian, nurse or other clinician with pharmacology for symptoms, 4 to 8 
ƌeƋuiƌes iŶteƌǀeŶtioŶ ďǇ a dietiĐiaŶ ǁith suppoƌt fƌoŵ Ŷuƌse aŶd otheƌ ĐliŶiĐiaŶs, aŶd a sĐoƌe ≥ϵ 
indicates a critical need for symptom management and nutritional intervention. Questions about 
socio-demographics were also included.  People affected by cancer (n=10) were invited to pilot the 
questionnaire using a think-aloud technique during completion, and their feedback informed the 
final version (see Appendix I).   
 
Data collection 
 
Clinic staff identified eligible patients and introduced them to the researcher (CK) who offered a 
study pack comprising of a Study Brochure and the survey questionnaire. The researcher invited the 
patient to complete the survey during their clinic visit or to return it by post in a stamped addressed 
envelope. Completion of the questionnaire was taken as evidence of consent to participate [14].  
 
Interviews  
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Semi-structured telephone interviews were conducted with a maximum variation sample of patients 
who complete the questionnaire (CK). The purpose was to explore the practical, social and 
emotional experience of eating through treatment and self-management of diet and weight. 
Interviews were performed until data saturation was achieved, defined as when three consecutive 
interviews produced no new issues [15].  
Analysis 
Survey data was entered into IBM SPSS for windows version 25 (CK) and analysed using descriptive 
statistics and graphical representations of data (JH) to determine the extent and pattern of eating 
and weight problems.  
Interview data was audio-recorded and transcribed verbatim by a professional transcription 
company. Transcriptions were coded in NVivo computer software (CK), to assist with data 
management. Transcripts and coding were read and re-read, then categorised inductively by two 
researchers working independently (CK, JH). The researchers compared their analysis and agreed 
final categorisation of the data. Categorisation and the identification of relationships between 
Đategoƌies ĐoŶfoƌŵed to Miles aŶd HuďeƌŵaŶ͛s ͚ŵiǆed stƌategǇ͛ foƌ Đase-study analysis [16]. Themes 
relating the categories were identified (CK, JH) and then organised using an approach informed by 
hermeneutic phenomenology [17] to provide description of physical, social and emotional 
experience and management of weight and eating during chemotherapy treatment, which revealed 
possible explanations of the survey results (JH). 
Wales NHS Ethics Committee 3 gave ethical approval for the study. Findings were shared with 
participants with consent. Anonymity was protected during reporting with patients denoted by P 
followed by their participant number.  
 
 
Results 
 
The survey questionnaire was returned by 52/92 patients (response rate 57%) with non-metastatic 
colorectal cancer, who were receiving treatment from November 2018 to June 2019. In this time 
period 132 eligible patients attended 70 clinics. Those not approached were, in clinic at a time the 
researcher was with another patient or not in attendance (n=27), did not speak English (n=2), were 
judged by a clinician as too unwell to approach (n=7), or declined to take part (n=4). Telephone 
interviews were then conducted with a maximum variation sample of 20 patients who completed 
the questionnaire to explore factors influencing nutritional self-care (see Table 1. Sample 
characteristics). 
 
Eating problems and nutritional impact symptoms 
 
Participants were asked if they were eating less or more than before the start of their treatment. 
26/50 (52%) of the patients who provided a response were found to eat less and 12/51 (24%) found 
to eat more. When asked about the nature of any eating difficulty, more than half reported lack of 
interest in food, feeling full too quickly and feeling put-off eating by the amount of food on a plate, 
with nearly a third forcing themselves to eat and a fifth unable to eat although they wanted to (see 
Table 2. Experience of eating problems). 
 
Participants were also invited to report nutritional impact symptoms. Overall, few symptoms were 
experienced and when they were, few patients reported severity to ďe ͚Ƌuite a ďit͛ oƌ ͚ǀeƌǇ ŵuĐh͛ 
(see Table 3. Nutritional impact symptoms). Nausea, dry mouth, lack of appetite, diarrhoea and 
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frequency of bowel movements were the most problematic. When asked if bowel movements had 
changed what was eaten, 42/50 (84%) ƌepoƌted ͚little͛ oƌ ͚Ŷot at all͛ aŶd ǁheŶ asked if ďoǁel 
movements had resulted in eating less, 48/50 (96%Ϳ ƌepoƌted ͚little͛ oƌ ͚Ŷot at all.͛ 
 
Changes in weight 
 
Fifty-one patients reported their weight at the time of questionnaire completion. The 32 men in the 
sample were mean weight 86kg (median 82kg, range 67kg to 121kg) and the 20 women were mean 
weight 78kg (median 75.5kg, range 51 to 122kg). Patients were also asked to report  their weight six 
months prior to completing the questionnaire. Forty-eight patients reported their weight at the two 
time points. Weight gain was reported by 12/48 (25%), 32/48 (67%) reported weight loss and 4/48 
(8%) were weight stable. Of the 19/48 (40%) patients who had lost more than 5% body weight, 
11/19 (58%) had lost weight during their chemotherapy treatment.   
 
Scored PG-SGA (nutritional risk screening) 
 
31 men completed the scored PG-SGA, with a mean score of 4.2 (median 3.0, range 0-17) and 20 
women completed the measure, with a mean score of 4.0 (median 3.0, range 0-11). In total, 
33/51(67%) were at ͚nutritional risk͛ with a PG-“GA sĐoƌe of ≥Ϯ. 11 men (35.5%) and 7 women (35%) 
were in the category ͛requiring no intervention.͛ Half of both the men 15/31 (48%) and women 
10/20 (50%) were at nutritional risk with score 2-8, where nutritional care and symptom 
management by the oncology team are important, whilst 5 men (16%) and 3 women (15%) were in 
the category indicating ͚critical need for intervention͛ (see Figure 2. Nutritional risk). 
 
Emotional impact of changes in eating and weight 
 
Despite more than two-thirds of participants being at nutritional risk, most were unconcerned about 
their eating or weight (see Figure 3.). When asked if they were concerned about eating, a high 
proportion, 40/51 (78%) responded no and similarly, when asked if they were concerned about their 
weight, 40/50 (80%) responded no.  
 
Participants also rated the intensity of possible concerns. When asked if concerned about appetite, 
ϱϭ/ϱϮ ;ϵϴ%Ϳ ƌepoƌted ͚Ŷot at all͛ oƌ ͚a little,͛ aŶd ǁheŶ asked to ƌate ǁoƌƌǇ aďout eatiŶg, 49/51 (96%) 
ƌepoƌted ͚Ŷot at all͛ oƌ ͚a little.͛ Of the 33 participants who were at nutritional risk with a PG-SGA 
sĐoƌe Ϯ oƌ gƌeateƌ, ϯϯ/ϯϯ ;ϭϬϬ%Ϳ ƌepoƌted ͚Ŷot at all͛ oƌ ͚a little͛ ĐoŶĐeƌŶ aďout appetite, aŶd ϯϭ/ϯϮ 
;ϵϳ%Ϳ ƌepoƌted ͚Ŷot at all͛ oƌ ͚a little͛ ǁoƌƌǇ aďout eatiŶg. 
 
Nutritional information and advice 
 
A total of 19/51 (36.5%) participants had received information about diet and nutrition from a 
healthcare professional and more than half, 28/51 (54%), had gathered dietary information from 
other places (see Table 4.). However, there was no correlation between receiving or seeking 
nutritional information and PG-SGA score. A ŵajoƌitǇ ϰϭ/ϱϬ ;ϴϮ%Ϳ ƌespoŶded ͚Ŷot at all͛ to a 
question asking if more should be done to help them eat. 
 
Interview findings  
 
Sample  
The interview sample (n=20) was selected to be representative of the whole sample (n=52). Similar 
proportions reported weight change, weight loss or weight gain during their chemotherapy 
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treatment, although a lower proportion had experienced >5% weight loss over six months (see Table 
1.).  
A range of practical, social and emotional factors influenced eating and the way in which people 
responded to change in eating habits and weight.  
 
Practical factors affecting dietary intake  
Common side effects 
The participants spoke about chemotherapy side effects and disease symptoms affecting what they 
were able to eat and drink, consistent with the questionnaire responses;  
͞Even water tasted funny, I had a job to drink water, um so food just tasted absolutely 
dreadful….the first Đouple of daǇs, I͛d haǀe a ďit of ĐoŶstipatioŶ aŶd theŶ diarrhoea set iŶ aŶd 
it would be on and off for the rest of the cycle.͟ (P31) 
However, side effects were fewer in number and less severe than expected:  
͞I get Ŷo siĐkŶess. NothiŶg. I thiŶk I͛ŵ oŶe of the lucky ones.͟ (P2) 
When asked about what they had eaten the day before the interview, more than half described their 
iŶtake as ͚Ŷoƌŵal͛ oƌ siŵilaƌ to ďefoƌe theiƌ ĐaŶĐeƌ diagŶosis. 
Strategies to eat and drink 
An approach for managing chemotherapy side effects at home used by some was to follow rules. 
These might be personal rules but informed by information and advice given by oncology staff. 
Advice to eat before taking chemotherapy medication was an important influence on the pattern of 
eating or the decision to eat at all; 
͞My portion sizes are smaller, um, because of my medication, I have to eat before I have my 
ŵediĐatioŶ. “o, I haǀe aŶ alarŵ oŶ ŵǇ phoŶe, to flash luŶĐhtiŵe, theŶ I go oh right okaǇ, I͛ǀe 
gotta remember to eat something.͟ (P33) 
Public health messages disseminated to the general population about what to eat and drink for 
health and well-being also influenced personal rules;  
͞We͛ǀe alǁaǇs eateŶ healthilǇ. Er, there͛s Ŷo frǇiŶg paŶ iŶ this house. We doŶ͛t haǀe sugar. 
We doŶ͛t use sugar. I had a ǁeak Đoffee, ďut ǁe usuallǇ driŶk ďoiled ǁater. Both of us, Ǉea, 
it͛s all fresh ǀegetaďles or, frozeŶ ǀegetaďles….We͛ǀe alǁaǇs eateŶ healthǇ, healthǇ salads 
aŶd fresh ǀegetaďles, fruit. We loǀe our fruit, so it͛s Ŷot ŵuĐh differeŶt to what it was before 
the cancer set in.͟ (P29)  
A temporary thing 
The side effects described as most hindering to eating were nausea and sickness, diarrhoea, loss of 
hunger/appetite, cold sensitivity to fluids and food leading to difficulty in keeping hydrated and also 
in handling food and drink. Any disruption to eating caused by chemotherapy side effects was ͚just 
oŶe of these thiŶgs Ǉou͛ǀe got to put up ǁith͛ (P12) and expected to be temporary; 
͞It͛s all part of the Đheŵo, oŶĐe Đheŵo fiŶishes, I think I will be a lot better.͟(P38) 
 
Social factors affecting dietary intake  
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Disruption of day to day activity 
 
The change in day to day activity, particularly for those who had stopped working during treatment, 
was a factor influencing dietary intake. P5 was concerned about weight gain;  
 
͞Once I go back to work my diet is gonna change, because, obviously at home you do tend to 
piĐk aŶd I doŶ͛t thiŶk that͛s doiŶg ŵe aŶǇ good. It͛s just, proďaďlǇ, ďoredoŵ aŶd stuff like 
that, I mean if I go out and come baĐk iŶ, I͛ll haǀe a ďisĐuit ǁith a Đup of tea, or a pieĐe of 
Đake aŶd a Đup of tea. It͛s oŶe of those thiŶgs that I ǁouldŶ͛t do iŶ ǁork.͟ (P5) 
 
Physical activity or exercise were talked about along with dietary intake, as important for managing 
weight. Some participants spoke about physical activity or exercise to have been an important part 
of their lives. Concern was expressed because of the difficulty in remaining physically active during 
treatment and the implications, especially for those who did not want to gain weight; 
 
͞I should ďe doiŶg a ďit ŵore eǆerĐise, ďut I ĐaŶ͛t do it at the ŵoŵeŶt, I tried to ǁalk a little 
ďit, ďut it͛s ǀerǇ, ǀerǇ tiriŶg aŶd I͛ŵ Ŷot ǀerǇ steadǇ oŶ ŵǇ feet.͟ (P20) 
A particular challenge for patients with a stoma who wanted to remain active, was concern about 
going out, because of the risk of a leak from the stoma bag. This affected their activity and also what 
they ate, with restriction of food and fluid intake being a way to manage the risk;  
 
͞I͛ǀe got a colostomy bag.…That͛s kiŶd of eŶĐouraged ŵe to Ŷot eat ǀerǇ ŵuĐh…..If I͛ŵ goiŶg 
out iŶ puďliĐ, I ǁoŶ͛t eat….If I͛ŵ goiŶg out, I͛ll aǀoid eatiŶg ǁhilst I͛ŵ out, aŶd theŶ I͛ll eat 
when I get back home.͟ (P17) 
 
Having another person either to feed, or who offered help with food preparation was helpful for 
those experiencing problems eating. To care for others, or care shown by others in providing food, 
was experienced as more than an offer of food for the body, but fuel for a sense of well-being. 
Patients who experienced the most difficulty finding the energy and motivation to attend to their 
nutritional intake were those who lived alone; 
 
͞BeĐause it͛s oŶlǇ ŵe iŶ the house….I trǇ aŶd Đook, I Đook diŶŶer, that͛s oŶlǇ oŶĐe a ǁeek 
now, it used to be every day.͟ (P38) 
 
 
A self-management routine 
 
When disruption in day to day activity was recognised as a risk to either taking adequate nutrition or 
eating too much, a proactive approach could include establishing a routine. The routine might be to 
engage in a distracting activity to avoid overeating. Foƌ eǆaŵple, ͚doiŶg jigsaǁs͛(P33). 
 
It might also include adapting an approach successful in managing a pre-cancer problem; 
 
͞What I alǁaǇs fiŶd helps ǁith ŵǇ ǁeight, to go to Đlass eǀerǇ ǁeek, to ǁeigh ŵǇself…. I 
used to enjoy going to the Slimming World classes to get tips from other people and the 
support ͚oh, ǁell doŶe͛ froŵ the other people. MǇ husďaŶd͛s oǀerǁeight, he͛s goŶe to ;the 
chemist) the last three weeks now to weight there, which only costs us seventy pence, weigh 
aŶd a little slip Đoŵes out, aŶd I started that Ŷoǁ last ǁeek…“o, we are supporting each 
other that way.͟ (P33) 
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P33 has not only resuming an old activity that has previously enabled her to manage her weight, but 
also engaged her husband in her weight management plan. A mutually beneficial activity is 
established, as a helpful routine within their personal capabilities and financial resources.  
 
Return to former activities, dietary habits and management of health was a recurring theme. The 
goal being to get back to normal;  
 
͞I just think keep going and trying to get back to normal and not sit around too much, you 
know, and get back to your normal activities.͟ (P27)  
 
Normal food and eating habits provided some reassurance of recovery; 
 
͞…. it ǁas the ďest I ǁas feeliŶg for, for ages.…, I ǁas aďle to eat ŶorŵallǇ͟ (P28) 
 
 
Emotional factors affecting dietary intake 
Getting better 
Many patients were seemingly unconcerned about their diet, nutritional intake or eating habits. 
They gave accounts of improvement in what they were able to eat and drink, which assured them all 
was well, that additional information and advice on food, eating and nutrition was unnecessary and 
there was nothing more to be done; 
͞I͛ŵ sure I read soŵeǁhere, oŶ oŶe of the leaflets that Ǉou Đould ask for dietarǇ adǀiĐe. 
AŶd…ďut I didŶ͛t reallǇ feel I Ŷeeded it.͟ (P8) 
Factors described as evidence of being on a pathway of recovery ǁeƌe ͚ŵiŶd ŵatters,͛ ͚healthǇ 
eating,͛ and ͚benefits of weight loss.͛ 
Mind matters  
Recurring were comments about positive thinking and having the right attitude for recovery; 
͞Although I͛ǀe reduĐed ŵǇ food, Ǉou kŶoǁ, for the ďag aŶd thiŶgs, I doŶ͛t let it get to ŵe…I 
just thiŶk, oh ǁell…I thiŶk a positiǀe ŵiŶd-set is the ŵaiŶ thiŶg….faith that eǀerǇthiŶg is 
going to be okay.͟ (P17) 
Clinical staff were seen responsible for medical treatments to manage the disease and its symptoms. 
Personal responsibility was to have a positive attitude. 
Healthy eating  
Having the right attitude included eating the right foods for recovery and health. A small number of 
patieŶts ͚ǁorried aďout the ŶutritioŶal side of thiŶgs͛ (P31). For these people, the right foods were 
believed to be the balanced diet recommended for the healthy population, to include fruit and 
vegetables every day. This proved challenging; 
͞I was concerned because, normally, my intake in nutrients and vitamins is normally quite 
high. I felt that because I was drawn to mainly just having lots of sandwiches and what I 
wanted, I was sort of fighting it at first, because I thought no I need to have my usual fruit 
aŶd ǀeg…iŶ the eŶd, I just thought, right, I just Ŷeed to giǀe iŶ to hoǁ I͛ŵ feeliŶg, ďeĐause 
there is enough going on without me fighting myself over diet.͟ (P7) 
Benefits of weight loss  
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It was more often that the patients considered weight rather than nutrition. They spoke about their 
current weight and weight change evidencing improvement in health;  
͞I͛ŵ keepiŶg to 11 ½ stoŶe Ŷoǁ. I͛ŵ happǇ ǁith that. I Ŷeeded to lose ǁeight aŶǇǁaǇ, I ǁas 
up to 14 ½ stoŶe, that͛s Ŷo good, that͛s Ŷo good to aŶǇďodǇ, ďut it͛s off Ŷoǁ aŶd I͛ŵ ǀerǇ 
pleased about it.͟ (P29) 
Most gave an account of their experience of surgery. Typically, this was of rapid weight loss followed 
by weight gain during the post-operative recovery period, which might be spontaneous or the result 
or effort of consciously ͚ďuildiŶg up agaiŶ͛ (P18). The benefits of weight loss were emphasised, 
particularly by those who had been overweight before the surgery, but also by patients who were 
not.  
͞I had the operation…. that just kŶoĐks ďaĐk Ǉour appetite, erŵ, ǁhether there͛s soŵe other 
ŵore ŵediĐal reasoŶ ǁhǇ I lost, I doŶ͛t kŶoǁ, ďut the result ǁas I lost ϴ or ϵ kilos. It ǁasŶ͛t a 
proďleŵ ďeĐause, although I Ŷot oǀerǁeight at all, it possiďlǇ didŶ͛t do ŵe aŶǇ harŵ to lose 
that.͟ (P23) 
Family members reinforced beliefs about the benefits of weight loss;  
͞… my family are very pro me losing weight. I have that pressure.͟ (P20) 
Patients who were gaining weight but who did not want to return to or become overweight, spoke 
about weight being out of their control during treatment. This might be because of the advice given 
to eat before taking oral chemotherapy to minimise treatment side effects; 
͞I͛d rather Ŷot put oŶ aŶǇ ŵore ǁeight ďut ….I guess I͛ŵ ďetǁeeŶ a roĐk aŶd a hard place 
really. I mean, I do need to eat so as I can take my chemo drugs.͟ (P16) 
Or, it was explained that steroid treatment ͚does increase your appetite; (P25)  and change in 
everyday activity, foƌ eǆaŵple ͚Ŷot ďeiŶg iŶ ǁork͛ (P25) had impact on dietary intake and weight. 
Nothing to be done and taking control 
Although there was a dominant shared narrative of weight and weight gain being out of control 
during cancer treatment – partly because of the disease treatment and treatment side effects – 
there was a competing narrative. This was the dominant narrative throughout six interviews with 
patients across the spectrum of nutritional risk, assessed using the PG-SGA, three of whom were 
weight gaining and three weight losing. It was of overtly taking control to aid recovery, in spite of 
this being difficult; 
͞I ŵake ŵǇself eat, eǀeŶ ǁheŶ I doŶ͛t ǁaŶt to. I trǇ aŶd keep it to three or four reasoŶaďle 
health meals a day, cos, as far as I can concentrate on good quality food as well than just 
gettiŶg soŵethiŶg iŶto ŵe, aŶd I do as ŵuĐh eǆerĐise as I ĐaŶ tolerate….It͛s Ǉou kŶoǁ, takiŶg 
ĐoŶtrol aŶd soŵetiŵes Ŷot feeliŶg like it, ďut kŶoǁiŶg that it, iŶ the loŶg ruŶ it͛s ǁhat ŵǇ 
ďodǇ Ŷeeds aŶd hoǁ I͛ŵ goŶŶa reĐoǀer…. A ďit of ĐoŶtrol oǀer ǁhat͛s goiŶg oŶ ǁith ŵe, I 
suppose, it͛s keepiŶg ŵǇself iŶ the ďest ĐoŶditioŶ that I ĐaŶ ǁhile I ĐaŶ͛t eǆerĐise aŶd eat 
what I would normally, I want to try and maintain at least a part of it. It gives you focus.͟ 
(P18) 
The two narratives of being ͚out of control͛ versus taking control, may be intertwined within a 
patieŶt͛s stoƌǇ. This was evident in accounts of internet use. P23 is an example of someone who 
talks about the internet as a source of information for managing diet and weight but who has 
confidence in his existing knowledge of diet and nutrition, so considers there is nothing to be done; 
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͞OŶe is aďle to Google….ǁhat͛s good to eat, whiĐh is proďaďlǇ Ŷot ǀerǇ Đleǀer. It͛s ďest to ask 
people, but err, no try and have a reasonable diet, you know, the reasonable fruit and 
vegetables.͟ (P23) 
 
5 patients actively avoided searching the iŶteƌŶet foƌ iŶfoƌŵatioŶ aďout diet aŶd ǁeight ͚you get 
iŶto a lot of ŵisiŶforŵatioŶ͛ (P9). It was considered a worrying or frightening thing to do. Thus, to do 
nothing was a passive way of taking control; 
 
͞I specifically avoided that, um, I know if you look something up on the internet, generally 
you just worry yourself to death, so I made a particular point of not looking stuff up.͟ (P25) 
 
Talking about the internet revealed the intertwined narratives of actively taking control by managing 
nutritional intake and physical activity through rules, routine and self-help, as compared to a more 
passive approach of drawing on existing knowledge and experieŶĐe to fiŶd oŶe͛s oǁŶ ǁaǇ aŶd ǁait 
for treatment–related problems to pass.  For those taking control passively, the intention was always 
to ͚just do thiŶgs ŶoƌŵallǇ ƌeallǇ͛ ;PϭϳͿ oƌ ƌetuƌŶ to Ŷoƌŵal; 
 
͞I was never really a big eater; ŵǇ Ŷorŵal staŶdard ǁeight is seǀeŶtǇ kilos ;….Ϳ I͛ŵ trǇiŶg to 
get my weight back to normal.͟ (P25)  
 
Making sense of the survey results and interview findings 
 
The majority of patients were at nutritional risk, but unconcerned about diet, eating and weight. An 
explanation for this lack of concern is the sense of control gained from taking the same diet as prior 
to their cancer diagnosis or from a belief in being on a pathway back to normal. This belief is 
reinforced by the improvement in dietary intake and recovery of weight loss post-surgery and prior 
to commencing chemotherapy, accompanied by fewer than expected side effects of chemotherapy. 
The assumed return to eating normally equated with recovery, contributed to ambivalence about 
actively managing dietary intake and the decision that there was nothing to be done until after 
chemotherapy treatment. A minority of patients gained a sense of control and well-being during 
chemotherapy treatment by actively seeking information and self-managing nutritional intake and 
weight. This minority spanned all categories of nutritional risk and included those who were both 
weight gaining and weight losing. Education to disrupt the goal of eating as normal (pre cancer) may 
be a way to facilitate change in self-management. There is potential for disruption of the belief that 
eating as normal is good, to enable a greater number of patients to actively self-manage, whether 
they are weight losing, weight gaining or at any level of nutritional risk. 
Discussion  
In this study, a majority of patients with non-metastatic colorectal cancer reported changes in eating 
habits during chemotherapy treatment and two-thirds were assessed to be at nutritional risk. 
Malnutrition can lead to weight loss or weight gain. Twenty five percent had gained weight and 67% 
had lost weight over a six-month period (37% after starting chemotherapy treatment). Concern 
regarding eating was reported by one in four (25%) who had gained weight and one in five (19%) 
who had lost weight, over six months. Thus, there was a large group of patients who had no eating 
concerns despite being at nutritional risk.    
 
The interviews revealed a dominant narrative of confidence in self-management of eating and 
weight, reinforced by weight gain accompanying recovery following surgery, which led to a belief 
that further dietary information or advice was unnecessary. Experience of overcoming eating 
problems and regaining weight lost pre- and immediately post operatively, plays an important role in 
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how people go on to manage eating whilst on chemotherapy. Confidence that recovery was in 
progress was further reinforced by the experience of fewer and less intense nutritional impact 
symptoms than were expected whilst on chemotherapy. Also, important to note, is that some 
patients welcomed weight loss. Of these, some welcomed weight loss because they had been 
overweight, as has previously been reported [18]. However, others did so despite having been 
underweight. 
 
Interest in nutritional care 
 
An on-line survey of 96 patients, most living in south or south-east England, 1/3rd with advanced 
disease, and 1/3rd with breast cancer, reported dissatisfaction with nutritional care and wanted 
additional advice on diet and nutrition during treatment to help them manage side-effects of 
chemotherapy, weight changes and what they eat [19]. Interview based studies evidence that 
patients find eating problems distressing and lack appropriate dietary instructions [20,21]. Yet there 
is competing evidence. Patients have also been found reluctant to engage in nutritional care. A study 
conducted in Turkey of mixed cancer sites reported that more than a third of patients declined 
participation because of fatigue or disinterest in nutritional support [22]. Our study demonstrated 
that diet and nutrition was of concern to only a minority of patients, despite the fact that it should 
have been of concern to all at nutritional risk. A majority were content with the nutritional advice 
and information available to them. The sample demographic was typical in terms of age, gender, 
ethnicity and domestic status of patients receiving treatment for colorectal cancer when compared 
with 857 colorectal cancer patients from 29 centres across the UK [23]. Lack of concern surrounding 
dietary intake and nutrition during chemotherapy for colorectal cancer may manifest beyond the 
study centre location in South Wales, UK. 
 
Clinical guidelines 
Nutritional counselling is the most often used intervention for patients with cancer who have a 
functioning gastrointestinal tract and are malnourished [24]. It can improve nutritional status in 
patients receiving chemotherapy [25]. In China, patients with gastric cancer receiving chemotherapy 
were randomised to intensive nutritional counselling or usual nutritional care (n=144). The 
intervention group had improved calorie and iron intake throughout treatment and fewer treatment 
interruptions compared to the usual care control. [26]. Critical components of nutritional counselling 
are to explain reasons for and agree goals of nutritional recommendations and to motivate the 
patient to adapt to the nutritional demands of their cancer [2]. These components are consistent 
with behavioural change theories and strategies known to facilitate food behaviour change beyond 
the context of cancer care [27].  
 
Personalised nutritional counselling and support for physical activity is recommended by the ESPEN 
Clinical Guideline on nutrition in cancer, to stabilise weight and prevent loss of muscle mass and 
function [2]. Counselling is recommended to support dietary adaptation using regular foods, fortified 
foods and oral food supplements [24] to achieve an intake of 25-30 kcal/kg/day and 1.2-1.5g 
protein/kg/day (or intake based on an estimate of energy needs) [24]. However, this knowledge 
alone may not change self-management of eating during treatment. Beliefs surrounding eating, such 
as perceived health benefits, not just symptoms such as taste change, constrain and enable 
management of eating problems [28]. Our study reveals participants were unconcerned about 
eating and mostly unaware of nutritional risk, and nutritional considerations influenced diet of only a 
minority. This minority were concerned to take control by eating the healthy diet promoted to 
prevent or reduce risk of disease. Dietary management has similarly been found an important way of 
feeling in control for breast [29] and prostate [30] cancer patients on treatment. 
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For a majority of our study participants, food and fluid intake was influenced by a desire to either 
continue as normal, or the hope of returning to normal. Thinking and behaviour was driven by 
normal symbolising recovery and thus giving comfort. It was feeling not fuelling that was important 
to self-management of diet, eating and weight during treatment. This suggests that, for care to be 
effective in supporting self-management of nutritional risk during chemotherapy treatment, it 
should focus not only on fuelling the body, advising the best nutrient intake, but also create a feel-
good factor.  
 
A personal reference point 
 
Normal eating habits or usual dietary intake prior to receiving a diagnosis of colorectal cancer was 
used by a majority of patients, as the reference point for recovery and indicator of health. This has 
implications for nutritional care during chemotherapy treatment. It seems likely that to be effective, 
nutritional counselling should advise adaptations as close as possible to the patieŶt͛s Ŷoƌŵal iŶtake 
and eating pattern, as has previously been recommended to support patients receiving radiotherapy 
[10]. It also raises a question about the potential for psychoeducation to change the reference point. 
For example, if the advised reference point was stable weight through treatment, as recommended 
by ESPEN, this may facilitate a guideline compliant dietary intake for patients receiving 
chemotherapy. In other words, it may encourage dietary intake, which can reduce the risk of 
interruptions to treatment schedule and improve quality of life through improved nutrition [24]. The 
approach may be particularly helpful for patients who self-manage eating during chemotherapy 
treatment by creating personal rules informed by healthcare professional advice.  
 
Limitations 
 
This research was a single centre study in the UK and was about nutritional care of patients receiving 
a single treatment modality, chemotherapy. Almost all patients with Stage I disease are treated by 
surgery alone, therefore it is likely that the analysis and conclusions are based on data collected 
from patients with Stage II-III colorectal cancer. The transferability of the findings to other disease 
stages, cancer treatments and other geographical locations in the UK and beyond, should be 
investigated with a larger sample size This would permit robust statistical tests of the propositions 
generated by the analysis and stratification to enable comparison of rectal and colon cancers and 
comparison of weight losing, weight gaining and weight stable patient groups. 
 Data collection was performed by a social scientist who then conducted the analysis in partnership a 
nurse academic. The findings have been tested for credibility through discussion with service users, 
cancer clinicians, clinical academics and researchers practising in England and Wales. Evaluation of 
credibility should be extended to include multidisciplinary cancer teams across all four nations in the 
UK and beyond. 
Conclusion and future perspective 
Patients with non-metastatic colorectal cancer receiving chemotherapy treatment were at 
nutritional risk, but few were concerned about dietary intake or weight. A minority sought to take 
control of their nutritional intake by striving to consume the healthy diet recommended to reduce 
risk of disease in the healthy population. A majority took comfort from continuing to eat normally or 
striving to return to normal pre-cancer dietary intake. Neither approach to self-management of 
eating and weight was consistent with achieving the nutritional intake recommended by the ESPEN 
Clinical Guideline on nutrition in cancer [24]. There is potential for psychoeducation to support 
change in self-management of nutritional risk, with the implication of a future with better 
chemotherapy tolerance and outcomes, including quality of life.  
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Table 1. Sample characteristics 
Sample characteristics 
 
Survey sample Interview sample 
Gender (n (%)) 
Female 
Male 
  
20 (38.5) 
32 (61.5) 
  
9 (45) 
11 (55) 
Age (years) 
Mean 
Median 
Range 
  
67 
68.5 
36 to 86 
  
64 
62 
48 to 84 
Ethnicity (n(%)) 
White British 
 
51/52 (98) 
 
19/20 (95) 
Education 
No formal qualification 
Trade qualification 
Higher degree 
 
10 (19) 
8 (15) 
10 (19) 
 
0 (0) 
3 (15) 
6 (30) 
 
Living with (n(%)) 
Partner/spouse 
Family  
Alone 
  
38 (73) 
4 (8) 
10 (19) 
  
16 (80) 
0 
4 (20) 
Cancer treatment (n(%)) 
Surgery 
Stoma 
  
Chemotherapy 
  
48 (92) 
19 (38) 
  
52 (100) 
  
20 (100) 
8 (44) 
  
20 (100) 
Time on treatment in weeks  
(median, mean (range) 
 
8.5, 11.6 (1 to 49) 
 
6.0, 11.2 (4 to 28) 
Comorbidity (n(%)) 
None 
Diabetes 
Heart disease 
Multiple 
  
19 (36.5) 
6 (11.5) 
6 (11.5) 
6 (11.5) 
  
8 (40) 
3 (15) 
3 (15) 
2 (10) 
PG-SGA (median, mean, (range) 
Nutritional risk score ≥Ϯ ;Ŷ;%ͿͿ 
3.00, 4.12 (0 to 17) 
 
33/51 (67) 
3.00, 4.1 (0 to 11) 
 
13/20 (65) 
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Visual Analog Scale (VAS) (median, mean, 
(range)) 
 
Eating-related concern 
Eating-related distress 
 
Weight-related concern 
Weight-related distress 
 
 
0.5, 1.8 (0 to 9.5) 
0.45, 1.1 (0 to 9.5) 
 
1.2, 2.3 (0 to 10) 
0.5, 1.5 (0 to 9.5) 
 
 
0.95, 2.31 (0 to 7.5) 
0.50, 1.41 (0 to 7.5) 
 
1.45, 2.44 (0 to 7.5) 
0.50, 1.41 (0 to 7.5) 
Eating change (n(%)) 
 
Eating more 
Eating less 
36/51 (71) 
 
12/51 (23.5) 
26/50 (52) 
12/20 (75) 
 
6/19 (32) 
8/18 (44) 
Weight in kg (median, mean, (range)) 78.0, 100.44, (50.8 to 
121.6) 
82.9, 84.94 (57.2 to 121.6) 
Weight change over 6 months based on self-
report of actual weight (n (%)) 
Stable 
Weight loss <5% 
Weight loss >5% 
Weight gain 
 
 
4/48 (8) 
13/48 (27) 
19/48 (40) 
12/48 (25) 
 
 
3 (15) 
7 (35) 
3 (15)  
7 (35) 
Weight change since commencing SACT 
based on self-report of YES/NO (n(%)) 
Weight has changed 
Weigh less 
Weigh more 
 
 
36/52 (70) 
18/50 (35) 
18/50 (35) 
 
 
12/20 (60) 
5/18 (28) 
6/18 (33) 
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Table 2. Experience of eating problems 
Problem A little, Quite a bit, Very much 
n,n,n=n/N(%) 
Not at all  
n(%) 
Put off by too much on plate 21,5,1 = 27/50 (54) 23/50 (46) 
Feeling full too quickly 19,3,4 = 26/50 (52) 24/50 (48) 
Lack of interest 16,8,2 = 26/50 (52) 24/50 (48) 
Trouble eating 15,4,1 = 20/49 (41) 29/49 (56) 
Problems with liquids 8,6,2 = 16/51 (32) 35/51 (69) 
Problems with solids 14,1,1 = 16/50 (32) 34/50 (68) 
Forced self to eat 11,2,2 = 15/50 (30) 35/50 (70) 
Put off by smell 8,4,2 = 14/49 (29) 35/49 (71) 
Food texture unpleasant 5,4,2=11/49 (23) 38/49 (78) 
Want to eat but unable 8,1,1 = 10/50 (20) 40/50 (80) 
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Table 3. Nutritional impact symptoms 
Most problematic nutritional impact 
symptoms (<10% eǆpeƌieŶced theŵ ͚Ƌuite 
a lot͛ oƌ ͚veƌǇ ŵuch͛Ϳ 
Least problematic nutritional impact 
sǇŵptoŵs ;>ϭϬ% eǆpeƌieŶced theŵ ͚Ƌuite 
a lot͛ oƌ ͚veƌǇ ŵuch͛Ϳ 
 
Nausea 
 
Vomiting 
 
Taste 
change 
 
Teeth 
 
Dry mouth 
 
Swallowing 
 
Lack of 
appetite 
 
Pain 
  
 
Tiredness 
  
 
Mouth ulcers 
 
Bowel symptoms 
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Diarrhoea 
 
Constipation 
 
Frequent 
bowel 
movements 
during the 
day 
  
 
Frequent 
bowel 
movements 
at night 
  
 
Bowel 
movements 
after eating 
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Table 4. Sources of nutritional information and advice 
 Information from 
a healthcare 
professional 
Information from 
other places 
PG-SGA score 
between 2 and 8 
offered 
healthcare 
professional 
advice 
PG-“GA sĐoƌe ≥ϵ 
offered 
healthcare 
professional 
advice 
Men 12/32 (37.5%) 17/31 (53%) 6/15 (40%) 3/5 (60%) 
Women 7/19 (35%) 11/19 (55%) 4/10 (40%) 1/3 (33%) 
     
Total 19/51 (36.5%) 28/51 (28%) 10/25 (40%) 4/8 (50%) 
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Figure 2. Nutritional risk 
 
 
 
 
Figure 3. Concern about eating and weight 
 
  
Analysis of the 
experience of 
eating and weight 
during 
chemotherapy 
treatment for 
stage I-III 
colorectal cancer 
and understanding 
of factors 
influencing self-
management of 
diet and weight
Systematic review of 
research about 
eating and cancer 
treatment conducted 
since 2011
(completed June 2017) Questionnaire distribution 
(n= approx. 100)
In clinics treating 
colorectal cancer 
patients with 
chemotherapy and 
interviews with a 
sub-sample of 
patients who 
complete the 
questionnaire
(n=max 30)
Weight and Eating 
Questionnaire 
for assessing 
eating and weight 
problems in 
colorectal cancer 
patients
PG-SGA
to assess nutrition 
risk
EORTC CAX24 
to assess weight and 
eating related quality 
of life 
Weight and Eating 
Questionnaire 
validated for use in 
advanced cancer
Figure 1.: Study design
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Appendix 1.: Questionnaire 
 
Section 1: About you  
 
 
Please insert or tick the answer that best applies to you: 
 
1. I am:  
            
 Male                 
 Female               
 Other              
 Prefer not to say 
 
2. MǇ date of ďiƌth ;DOBͿ is:………/…………/………. 
 
3. I am currently receiving  (please tick all that apply): 
 
     Chemotherapy 
     Immunotherapy 
     Hormone Therapy 
     Otheƌ ;please stateͿ …………………..………………… 
 
4. I have had surgery:                             YES                  NO 
 
5. I staƌted CheŵotheƌapǇ iŶ:  MoŶth…………….. Yeaƌ………………….     
 
I staƌted IŵŵuŶotheƌapǇ iŶ:  MoŶth…………… Yeaƌ………………….       
6. I have the following (please tick all that apply): 
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     Diabetes      
     Heart Disease/ Heart attack/ High blood pressure 
     Stroke 
     Lung disease/breathing problems 
     GastƌoiŶtestiŶal disoƌdeƌs ;CƌohŶ͛s/ Iƌƌitaďle Boǁel Disease IBDͿ 
     Arthritis 
     Otheƌ ;please stateͿ………………………………………………….. 
 
7. I currently live with: 
 
      Spouse/partner     
     Other family members 
     Alone 
     Other 
     Prefer not to say 
 
8. I have the following (please tick highest):  
 
     Trade/NVQ    
     GCSE/O Level 
     A level or Equivalent 
     Degree/Higher Degree 
     No Formal Qualification 
     Other  
     Prefer not to say 
9. I am:  
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     White British    
     White Other 
     Mixed/Multiple Ethnic Groups 
     Asian/Asian British 
     Black/African/Caribbean/Black British 
     Other  
     Prefer not to say 
  
      
 
We are interested in your experience of eating since you started your current Chemotherapy. Please read the 
questions below and circle the answer that best applies to you. There are no right or wrong answers.  
 
Please circle one answer per question. 
 
Since starting my current Chemotherapy: 
 
1. MǇ eatiŶg haďits haǀe ĐhaŶged ……………………………........................................ 
 
YES  /  NO 
2. I eat more Ŷoǁ thaŶ ďefoƌe I staƌted tƌeatŵeŶt……………………………………….. 
 
YES  /  NO 
3. I eat less Ŷoǁ thaŶ ďefoƌe I staƌted tƌeatŵeŶt………………………………………… 
 
YES  /  NO 
4. I haǀe ŵade ĐhaŶges to the ǁaǇ I eat………………………………………………… 
 
   YES  /  NO 
5. I haǀe ĐoŶĐeƌŶs aďout eatiŶg. ………………………………………………………… YES  /  NO 
 
Section 2: Your Eating Experience 
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6. My family is concerned about my eating haďits……………………………………… 
 
YES  /  NO 
 
7. I haǀe ďeeŶ giǀeŶ adǀiĐe aďout eatiŶg ďǇ a healthĐaƌe pƌofessioŶal….……………… 
 
YES  /  NO 
8. I haǀe fouŶd dietaƌǇ iŶfoƌŵatioŶ fƌoŵ otheƌ plaĐes e.g. iŶteƌŶet, leaflets, ďooks……. YES  /  NO 
 
 
 
 
Some people have problems eating during their treatment. 
     
 
Since starting your current Chemotherapy: 
 
 
 
 
Not at 
all 
  
 
A  
little 
Quite a 
bit 
Very 
much 
     
9. Have you had trouble eating? 
 
1 2 3 4 
10. Have you lacked appetite? 
 
1 2 3 4 
11. Has food tasted different from usual? 
 
1 2 3 4 
12. Have you found the texture of food unpleasant? 1 2 3 4 
13. Have you been put off eating by the smell of food? 
 
1 2 3 4 
14. Have you been put off eating by having too much food on your 
plate? 
 
1 2 3 4 
15. Have you felt full too quickly after beginning to eat? 1 2 3 4 
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Since starting your current Chemotherapy: 
 
 
 
 
Not at 
all 
 
 
A  
Little 
 
 
 
Quite a 
bit 
 
 
 
Very 
much 
 
16. Have you lacked interest in eating? 1 2 3 4 
17. Have you had problems drinking liquids? 
 
1 2 3 4 
18. Have you had problems eating solid foods? 
 
1 2 3 4 
19. Have you been unable to eat despite wanting to? 
 
1 2 3 4 
20. Have you forced yourself to eat? 
 
1 2 3 4 
     
Some people have symptoms or treatment side effects that interfere with their eating. 
 
  
Since starting your current Chemotherapy: 
 
 
Not at 
all 
 
 
A  
little 
Quite a 
bit 
Very 
much 
 
21. Have you vomited? 
 
 
1 
 
2 
 
3 
 
4 
22. Have you felt nauseated? 
 
1 2 3 4 
23. Have you had soreness or ulcers in your mouth? 
 
1 2 3 4 
24. Have you had a dry mouth? 
 
1 2 3 4 
25. Have you had problems with your teeth? 
 
1 2 3 4 
26. Have you had problems swallowing? 
 
1 2 3 4 
27. Have you been in too much pain to eat? 1 2 3 4 
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28. Have you been too tired to eat? 
 
 
1 2 3 4 
     
Some people have bowel problems that interfere with their eating. 
 
    
Since starting your current Chemotherapy:  
Not at 
all 
 
A  
Little 
 
Quite a 
bit 
 
Very 
much 
 
29. Have you been constipated? 
 
1 2 3 4 
30. Have you had diarrhea? 
 
1 2 3 4 
31. Have you had frequent bowel movements during the day?  
 
1 2 3 4 
32. Have you had frequent bowel movements during the night?  
 
1 2 3 4 
33. Have bowel movements occurred straight after eating? 
 
1 2 3 4 
34.  Have you felt embarrassed because of your bowel movement? 
 
1 2 3 4 
35.  Have your bowel movements changed what you choose to eat? 
 
1 2 3 4 
36. Have your bowel movements made you eat less?  
 
 
1 2 3 4 
37.  Do you have a stoma bag (colostomy/ileostomy)?  
 
Yes  No  
 
 
    
Some people have concerns about eating.     
Since starting your current Chemotherapy:     
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Not at 
all 
A 
little 
Quite a 
bit 
Very 
much 
38. Have you felt concerned about your appetite? 1 2 3 4 
 
39. Have you felt embarrassed when eating? 
 
1 2 3 4 
40. Have you felt guilty when eating? 
 
1 2 3 4 
41. Have you felt pressured by other people to eat more? 1 2 3 4 
42. Have you had trouble eating in front of other people? 
 
1 2 3 4 
43. Have you felt other people disapprove of what you eat?  
 
1 2 3 4 
44. Have you felt troubled by advice about eating from family and 
friends? 
 
1 2 3 4 
45. Have you felt troubled by advice from healthcare professionals? 
 
1 2 3 4 
46. Have you felt more should be done to help you eat? 
 
1 2 3 4 
47. Have you worried about eating? 
 
1 2 3 4 
 
For the following questions please rate how you have felt about your eating habits since starting 
your current treatment. Please mark the line with an X.   
 
How much concern has eating caused you? 
  
 
 
          
          
          
No 
concern 
Extreme 
concern 
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How much distress has eating caused you? 
 
 
 
 
 
 
 
We are also interested in some things about your weight since you started your current 
Chemotherapy. Please read the questions below and circle the answer that best applies to you. 
There are no right or wrong answers.  
 
 
Please circle one answer per question. 
 
Since starting my current Chemotherapy: 
 
48. MǇ ǁeight has ĐhaŶged..…………………………………………….. 
 
YES  /  NO 
49. I weigh less Ŷoǁ thaŶ ďefoƌe I staƌted tƌeatŵeŶt……………………... 
 
YES  /  NO 
50. I weigh more Ŷoǁ thaŶ ďefoƌe I staƌted tƌeatŵeŶt……………………. YES  /  NO 
51. I aŵ ĐoŶĐeƌŶed aďout ŵǇ ǁeight. ……………………………………. 
 
YES  /  NO 
52. MǇ faŵilǇ is ĐoŶĐeƌŶed aďout ŵǇ ǁeight. …………………………… 
 
YES  /  NO 
 
53. I currently weigh about                         ……………………………… 
  
DoŶ͛t kŶoǁ 
 
54. “iǆ ŵoŶths ago I ǁeighed aďout           ……………………………… 
 
DoŶ͛t kŶoǁ 
 
 
          
No 
distress 
Extreme 
distress 
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For the following question please rate how you have felt about your weight since starting your current 
treatment. Please mark the line with an X.   
 
How much concern has your weight caused you? 
  
 
 
 
How much distress has your weight caused you? 
 
 
 
 
 
 
 
Scored PG-SGA (Patient Generated Subjective Global Assessment) 
 
 
 
 
 
 
 
 
           
           
          
          
 
Section 3: Nutritional Risk Assessment 
 
No 
concern 
 
Extreme 
concern 
 
No 
distress Extreme 
distress 
